624 A phase I/II study evaluating the safety and efficacy of a novel long-acting interleukin-7, NT-I7, for patients with newly diagnosed high-grade gliomas after chemoradiotherapy
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.